Investigating the changing definitions, phenotypes, and treatments for BPD in preterm infants. Presentations will examine anti-inflammatory therapy, caffeine administration, and stem cell studies. Panelists will discuss long-term pulmonary outcomes and strategies for risk reduction. Focus on multidisciplinary care models involving pulmonologists, nutritionists, and therapists. New diagnostic imaging and monitoring equipment will also be featured. Appropriate for neonatologists and pediatric pulmonology staff.